目的 :设计小鼠 Retn基因特异性的 si RNAs,并构建一系列能在哺乳动物细胞内稳定表达这些 si RNAs的表达质粒 ,以便为在体外研究 Retn基因的功能打下基础。 方法 :(1 )设计并合成小鼠 Retn基因特异性的一组寡核苷酸片段 ,并克隆到 p Sil...目的 :设计小鼠 Retn基因特异性的 si RNAs,并构建一系列能在哺乳动物细胞内稳定表达这些 si RNAs的表达质粒 ,以便为在体外研究 Retn基因的功能打下基础。 方法 :(1 )设计并合成小鼠 Retn基因特异性的一组寡核苷酸片段 ,并克隆到 p Silencer EM 1 .0 - N eo载体 ;(2 )用电穿孔转染和 G4 1 8筛选等方法建立能稳定表达相应 si RNAs的一组 3T3- L1细胞克隆 ;(3)诱导细胞分化为脂肪细胞 ,并用 RT- PCR分析这些脂肪细胞内 Retn基因的 m RNA水平。 结果 :设计并构建了 4个小鼠Retn基因特异性的 si RNAs表达质粒 ,并证明其中的 2种质粒能在脂肪细胞内稳定表达相应的 si RNAs,显著地抑制了这些脂肪细胞内 Retn基因的 m RNA水平。 结论 :本研究设计并构建出的小鼠 Retn基因特异性的 si RNAs表达载体 ,所表达的 si R-NAs具有较强的 RNA干涉功能 ,为展开更多
Objective To observe the effects of PSD95 gene specific siRNAs on neuropathic pain relief, neuron viability, and postsynaptic calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) phosphorylation in vitro and in...Objective To observe the effects of PSD95 gene specific siRNAs on neuropathic pain relief, neuron viability, and postsynaptic calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) phosphorylation in vitro and in vivo. Methods Gene-specific siRNAs of rat PSD95 were synthesized chemically for transfection. Adult male Sprague-Dawley (SD) rats were randomly divided into 3 groups: nave group (n=6), sham group (n=6), and sciatic nerve chronic constriction injury (CCI) group (n=24). The CCI group was further divided into 4 groups (n=6 in each group), which were pretreated with normal saline, transfection vehicle, negative control siRNAs, and PSD95 gene specific siRNAs respectively. All the subgroups received corresponding agents intrathecally for 3 days, started one day before the CCI of sciatic nerve. Both mechanical allodynia and thermal hyperalgesia were measured on post-operative day 3 and 7. PSD95 gene silenced NG108-15 cells were further stimulated by glutamate, with the cell viability and the expression/phosphorylation of CaMKIIα measured by MTT cell proliferation assay and Western blot, respectively. Results The siRNAs decreased PSD95 mRNA level significantly both in vivo and in vitro. Neuropathic pain rats pretreated with PSD95 gene specific siRNAs exhibited significant elevation in the mechanical withdrawal threshold and paw withdrawal thermal latency, without affecting the baseline nociception. PSD95 gene silencing enhanced neuronal tolerance against the glutamate excitotoxicity, meanwhile the phosphorylation of CaMKIIα Thr286 was attenuated. Conclusion Pre-emptive administration of PSD95 gene specific siRNAs may attenuate the central sensitization CaMKIIα-related signaling cascades, leading to the relief of neuropathic pain.展开更多
Tomato has emerged as an emblematic model plants for fleshy fruit research and tomato fruit ripening is a complex and highly coordinated developmental process.The many physiology and biochemical processes associated w...Tomato has emerged as an emblematic model plants for fleshy fruit research and tomato fruit ripening is a complex and highly coordinated developmental process.The many physiology and biochemical processes associated with tomato fruit ripening require changes in the expression of hundreds to thousands of genes.Gene expression is regulated by transcriptional and post-transcriptional pathways,one of the recently discovered mechanisms in plants was small RNAs mediated gene silencing at post-transcriptional(PTGS) level.Intriguingly,several mi RNAs and endogenous si RNAs were revealed to be involved in the fruit ripening process which opened a new avenue in the field of fleshy fruit biology.This review compiled the most recent advances made in deciphering the regulation functions of mi RNAs and si RNAs in tomato fruit ripening.It also emphasized the new perspectives now possible in the small RNAs regulation research in tomato fruit ripening and senescence.展开更多
RNA interference (RNAi) is a process by which introduced small interfering RNA (siRNA) can cause the specific degradation of mRNA with identical sequences. The human herpes simplex virus type 1 (HSV-1) RR is composed ...RNA interference (RNAi) is a process by which introduced small interfering RNA (siRNA) can cause the specific degradation of mRNA with identical sequences. The human herpes simplex virus type 1 (HSV-1) RR is composed of two distinct homodimeric subunits encoded by UL39 and UL40,respectively. In this study,we applied siRNAs targeting the UL39 and UL40 genes of HSV-1. We showed that synthetic siRNA silenced effectively and specifically UL39 and UL40 mRNA expression and inhibited HSV-1 replication. Our work offers new possibilities for RNAi as a genetic tool for inhibition of HSV-1 replication.展开更多
Nanog, Oct4 and Sox2 are important transcription factors that are expressed in embryonic stem （ES） cells or embryonic carcinoma （EC） cells, but in most cases they are absent in somatic cells. These factors play a ...Nanog, Oct4 and Sox2 are important transcription factors that are expressed in embryonic stem （ES） cells or embryonic carcinoma （EC） cells, but in most cases they are absent in somatic cells. These factors play a key role to maintain embryonic stem cell self-renew and pluripotency. Down-regulation of Nanog and Sox2 gene expression can change multiple gene expression pattems and signal transduction pathways, and will initiate ES cell differentiation. This study was designed to select the efficient small interfering RNA （siRNA） fragments that inhibit Nanog and Sox2 gene expression in mouse J1 ES cells and P19 EC cells. Among synthesized siRNAs we screened out the siRNA N301 for Nanog and siRNA $720 for Sox2, which not only down- regulated of Nanog and Sox2 gene expression, but also interfered embryoid bodies formation. Our study provided the defined siRNA fragments that could be used to investigate the epigenetic function of Nanog and Sox2 genes.展开更多
RNA interference(RNAi) is a powerful tool for functional gene analysis which has been successfully used to downregulate the expression levels of target genes.The goal of this research was to provide a highly robust an...RNA interference(RNAi) is a powerful tool for functional gene analysis which has been successfully used to downregulate the expression levels of target genes.The goal of this research was to provide a highly robust and concise methodology for in-vitro screening of efficient siRNAs from a bulk to be used as a tool to protect potato plants against PVY invasion.In our study,a 480bp fragment of the capsid protein gene of potato virus Y(CP-PVY) was used as a target to downregulate PVY mRNA expression in-vitro,as the CP gene interferes with viral uncoating,translation and replication.A total of six siRNAs were designed and screened through transient transfection assay and knockdown in expression of CP-PVY mRNA was calculated in CHO-k cells.CP-PVY mRNA knockdown efficiency was analyzed by RT-PCR and real-time PCR of CHO-k cells co-transfected with a CP gene construct and siRNAs.Six biological replicates were performed in this study.In our findings,one CP gene specific siRNA out of a total of six was found to be the most effective for knockdown of CP-PVY mRNA in transfected CHO-k cells by up to 80%-90%.展开更多
目的探究NBR1对过量氟致成釉细胞氧化应激损伤的影响。方法取LS8细胞进行培养,待密度达70%~80%时,分别加入含Na F 0、1、2、4、8 m M的培养基培养24 h,另外,将加有2.0 m M Na F培养基的细胞分别培养至0、6、12、24、48 h,q RT-PCR和West...目的探究NBR1对过量氟致成釉细胞氧化应激损伤的影响。方法取LS8细胞进行培养,待密度达70%~80%时,分别加入含Na F 0、1、2、4、8 m M的培养基培养24 h,另外,将加有2.0 m M Na F培养基的细胞分别培养至0、6、12、24、48 h,q RT-PCR和Western blot分别测NBR1 mRNA和蛋白水平。化学合成NBR1 siRNA,转染LS8细胞后行2 m M Na F刺激,24 h后测Sod、Gpx1 mRNA和cyto c、γ-H2AX蛋白表达。结果不同浓度Na F(0~8 m M)作用LS8细胞24 h后,随着Na F浓度增加,NBR1蛋白表达呈剂量依赖性增加。当作用于LS8细胞的Na F浓度为2 m M时,随着时间增加,NBR1蛋白表达呈时间依赖性增加。q RT-PCR结果显示2 m M Na F处理LS8细胞24 h后,NBR1 mRNA水平显著增加。NBR1 siRNA干扰LS8细胞后,与对照组比较,NBR1 siRNA显著抑制NBR1表达。Na F处理的细胞中Sod、Gpx1 mRNA水平显著下降,cyto c、γ-H2AX蛋白表达显著增加,与Na F+GFP处理组相比,NBR1 siRNA和Na F共同处理细胞后,Sod、Gpx1 mRNA水平明显下降,cyto c、γ-H2AX蛋白水平明显增加。结论NBR1可能抑制过量氟导致的成釉细胞氧化应激损伤。展开更多
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of neurons in the central or peripheral nervous system.Currently,there is no cure for neurodegenerative diseases and th...Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of neurons in the central or peripheral nervous system.Currently,there is no cure for neurodegenerative diseases and this means a heavy burden for patients and the health system worldwide.Therefore,it is necessary to find new therapeutic approaches,and antisense therapies offer this possibility,having the great advantage of not modifying cellular genome and potentially being safer.Many preclinical and clinical studies aim to test the safety and effectiveness of antisense therapies in the treatment of neurodegenerative diseases.The objective of this review is to summarize the recent advances in the development of these new technologies to treat the most common neurodegenerative diseases,with a focus on those antisense therapies that have already received the approval of the U.S.Food and Drug Administration.展开更多
Anti-tumor angiogenesis therapy, targeting the suppression of blood vessel growth in tumors, presents a potent approach in the battle against cancer. Traditional therapies have primarily concentrated on single-target ...Anti-tumor angiogenesis therapy, targeting the suppression of blood vessel growth in tumors, presents a potent approach in the battle against cancer. Traditional therapies have primarily concentrated on single-target techniques, with a specific emphasis on targeting the vascular endothelial growth factor, but have not reached ideal therapeutic efficacy. In response to this issue, our study introduced a novel nanoparticle system known as CS-siRNA/PEITC&L-cRGD NPs. These chitosan-based nanoparticles have been recognized for their excellent biocompatibility and ability to deliver genes. To enhance their targeted delivery capability, they were combined with a cyclic RGD peptide (cRGD). Targeted co-delivery of gene and chemotherapeutic agents was achieved through the use of a negatively charged lipid shell and cRGD, which possesses high affinity for integrin αvβ3 overexpressed in tumor cells and neovasculature. In this multifaceted approach, co-delivery of VEGF siRNA and phenethyl isothiocyanate (PEITC) was employed to target both tumor vascular endothelial cells and tumor cells simultaneously. The co-delivery of VEGF siRNA and PEITC could achieve precise silencing of VEGF, inhibit the accumulation of HIF-1α under hypoxic conditions, and induce apoptosis in tumor cells. In summary, we have successfully developed a nanoparticle delivery platform that utilizes a dual mechanism of action of anti-tumor angiogenesis and pro-tumor apoptosis, which provides a robust and potent strategy for the delivery of anti-cancer therapeutics.展开更多
文摘目的 :设计小鼠 Retn基因特异性的 si RNAs,并构建一系列能在哺乳动物细胞内稳定表达这些 si RNAs的表达质粒 ,以便为在体外研究 Retn基因的功能打下基础。 方法 :(1 )设计并合成小鼠 Retn基因特异性的一组寡核苷酸片段 ,并克隆到 p Silencer EM 1 .0 - N eo载体 ;(2 )用电穿孔转染和 G4 1 8筛选等方法建立能稳定表达相应 si RNAs的一组 3T3- L1细胞克隆 ;(3)诱导细胞分化为脂肪细胞 ,并用 RT- PCR分析这些脂肪细胞内 Retn基因的 m RNA水平。 结果 :设计并构建了 4个小鼠Retn基因特异性的 si RNAs表达质粒 ,并证明其中的 2种质粒能在脂肪细胞内稳定表达相应的 si RNAs,显著地抑制了这些脂肪细胞内 Retn基因的 m RNA水平。 结论 :本研究设计并构建出的小鼠 Retn基因特异性的 si RNAs表达载体 ,所表达的 si R-NAs具有较强的 RNA干涉功能 ,为
基金Supported by National Natural Science Foundation of China (30672029, 30872436)Central Committee Foundation of Health Care Program (B2009B076)
文摘Objective To observe the effects of PSD95 gene specific siRNAs on neuropathic pain relief, neuron viability, and postsynaptic calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) phosphorylation in vitro and in vivo. Methods Gene-specific siRNAs of rat PSD95 were synthesized chemically for transfection. Adult male Sprague-Dawley (SD) rats were randomly divided into 3 groups: nave group (n=6), sham group (n=6), and sciatic nerve chronic constriction injury (CCI) group (n=24). The CCI group was further divided into 4 groups (n=6 in each group), which were pretreated with normal saline, transfection vehicle, negative control siRNAs, and PSD95 gene specific siRNAs respectively. All the subgroups received corresponding agents intrathecally for 3 days, started one day before the CCI of sciatic nerve. Both mechanical allodynia and thermal hyperalgesia were measured on post-operative day 3 and 7. PSD95 gene silenced NG108-15 cells were further stimulated by glutamate, with the cell viability and the expression/phosphorylation of CaMKIIα measured by MTT cell proliferation assay and Western blot, respectively. Results The siRNAs decreased PSD95 mRNA level significantly both in vivo and in vitro. Neuropathic pain rats pretreated with PSD95 gene specific siRNAs exhibited significant elevation in the mechanical withdrawal threshold and paw withdrawal thermal latency, without affecting the baseline nociception. PSD95 gene silencing enhanced neuronal tolerance against the glutamate excitotoxicity, meanwhile the phosphorylation of CaMKIIα Thr286 was attenuated. Conclusion Pre-emptive administration of PSD95 gene specific siRNAs may attenuate the central sensitization CaMKIIα-related signaling cascades, leading to the relief of neuropathic pain.
基金Supported by the National Natural Sciences Foundation of China(31401536)the Natural Science Foundation of Beijing(6144020)+1 种基金the Special Fund of China Agriculture Research System(CARS-25)the Special Fund for Agro-scientific Research in the Public Interest(201203095)
文摘Tomato has emerged as an emblematic model plants for fleshy fruit research and tomato fruit ripening is a complex and highly coordinated developmental process.The many physiology and biochemical processes associated with tomato fruit ripening require changes in the expression of hundreds to thousands of genes.Gene expression is regulated by transcriptional and post-transcriptional pathways,one of the recently discovered mechanisms in plants was small RNAs mediated gene silencing at post-transcriptional(PTGS) level.Intriguingly,several mi RNAs and endogenous si RNAs were revealed to be involved in the fruit ripening process which opened a new avenue in the field of fleshy fruit biology.This review compiled the most recent advances made in deciphering the regulation functions of mi RNAs and si RNAs in tomato fruit ripening.It also emphasized the new perspectives now possible in the small RNAs regulation research in tomato fruit ripening and senescence.
基金The Nation "863" Program of China(2006AA02A226)The Joint Funds of National Science Foundation of China (U0632010)+2 种基金The State KeyLaboratory of Phytochemistry and Plant Resources in West ChinaChinese Academy of Sciences (O807B11211, O807E21211)"211 grant of MOE"
文摘RNA interference (RNAi) is a process by which introduced small interfering RNA (siRNA) can cause the specific degradation of mRNA with identical sequences. The human herpes simplex virus type 1 (HSV-1) RR is composed of two distinct homodimeric subunits encoded by UL39 and UL40,respectively. In this study,we applied siRNAs targeting the UL39 and UL40 genes of HSV-1. We showed that synthetic siRNA silenced effectively and specifically UL39 and UL40 mRNA expression and inhibited HSV-1 replication. Our work offers new possibilities for RNAi as a genetic tool for inhibition of HSV-1 replication.
基金supported by the National Natural Science Foundation of China (30871786)the National Basic Research Program of China (973 Program,2009CB941002)
文摘Nanog, Oct4 and Sox2 are important transcription factors that are expressed in embryonic stem （ES） cells or embryonic carcinoma （EC） cells, but in most cases they are absent in somatic cells. These factors play a key role to maintain embryonic stem cell self-renew and pluripotency. Down-regulation of Nanog and Sox2 gene expression can change multiple gene expression pattems and signal transduction pathways, and will initiate ES cell differentiation. This study was designed to select the efficient small interfering RNA （siRNA） fragments that inhibit Nanog and Sox2 gene expression in mouse J1 ES cells and P19 EC cells. Among synthesized siRNAs we screened out the siRNA N301 for Nanog and siRNA $720 for Sox2, which not only down- regulated of Nanog and Sox2 gene expression, but also interfered embryoid bodies formation. Our study provided the defined siRNA fragments that could be used to investigate the epigenetic function of Nanog and Sox2 genes.
文摘RNA interference(RNAi) is a powerful tool for functional gene analysis which has been successfully used to downregulate the expression levels of target genes.The goal of this research was to provide a highly robust and concise methodology for in-vitro screening of efficient siRNAs from a bulk to be used as a tool to protect potato plants against PVY invasion.In our study,a 480bp fragment of the capsid protein gene of potato virus Y(CP-PVY) was used as a target to downregulate PVY mRNA expression in-vitro,as the CP gene interferes with viral uncoating,translation and replication.A total of six siRNAs were designed and screened through transient transfection assay and knockdown in expression of CP-PVY mRNA was calculated in CHO-k cells.CP-PVY mRNA knockdown efficiency was analyzed by RT-PCR and real-time PCR of CHO-k cells co-transfected with a CP gene construct and siRNAs.Six biological replicates were performed in this study.In our findings,one CP gene specific siRNA out of a total of six was found to be the most effective for knockdown of CP-PVY mRNA in transfected CHO-k cells by up to 80%-90%.
文摘目的探究NBR1对过量氟致成釉细胞氧化应激损伤的影响。方法取LS8细胞进行培养,待密度达70%~80%时,分别加入含Na F 0、1、2、4、8 m M的培养基培养24 h,另外,将加有2.0 m M Na F培养基的细胞分别培养至0、6、12、24、48 h,q RT-PCR和Western blot分别测NBR1 mRNA和蛋白水平。化学合成NBR1 siRNA,转染LS8细胞后行2 m M Na F刺激,24 h后测Sod、Gpx1 mRNA和cyto c、γ-H2AX蛋白表达。结果不同浓度Na F(0~8 m M)作用LS8细胞24 h后,随着Na F浓度增加,NBR1蛋白表达呈剂量依赖性增加。当作用于LS8细胞的Na F浓度为2 m M时,随着时间增加,NBR1蛋白表达呈时间依赖性增加。q RT-PCR结果显示2 m M Na F处理LS8细胞24 h后,NBR1 mRNA水平显著增加。NBR1 siRNA干扰LS8细胞后,与对照组比较,NBR1 siRNA显著抑制NBR1表达。Na F处理的细胞中Sod、Gpx1 mRNA水平显著下降,cyto c、γ-H2AX蛋白表达显著增加,与Na F+GFP处理组相比,NBR1 siRNA和Na F共同处理细胞后,Sod、Gpx1 mRNA水平明显下降,cyto c、γ-H2AX蛋白水平明显增加。结论NBR1可能抑制过量氟导致的成釉细胞氧化应激损伤。
基金supported by Association 2HE(Center for Human Health and Environment)by Regione Puglia-Grant Malattie Rare DUP n.246 of 2019(to CB).
文摘Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of neurons in the central or peripheral nervous system.Currently,there is no cure for neurodegenerative diseases and this means a heavy burden for patients and the health system worldwide.Therefore,it is necessary to find new therapeutic approaches,and antisense therapies offer this possibility,having the great advantage of not modifying cellular genome and potentially being safer.Many preclinical and clinical studies aim to test the safety and effectiveness of antisense therapies in the treatment of neurodegenerative diseases.The objective of this review is to summarize the recent advances in the development of these new technologies to treat the most common neurodegenerative diseases,with a focus on those antisense therapies that have already received the approval of the U.S.Food and Drug Administration.
基金supported by Guangdong Basic and Applied Basic Research Foundation(2023A1515010969)Natural Science Foundation of Top Talent of SZTU(GDRC202305).
文摘Anti-tumor angiogenesis therapy, targeting the suppression of blood vessel growth in tumors, presents a potent approach in the battle against cancer. Traditional therapies have primarily concentrated on single-target techniques, with a specific emphasis on targeting the vascular endothelial growth factor, but have not reached ideal therapeutic efficacy. In response to this issue, our study introduced a novel nanoparticle system known as CS-siRNA/PEITC&L-cRGD NPs. These chitosan-based nanoparticles have been recognized for their excellent biocompatibility and ability to deliver genes. To enhance their targeted delivery capability, they were combined with a cyclic RGD peptide (cRGD). Targeted co-delivery of gene and chemotherapeutic agents was achieved through the use of a negatively charged lipid shell and cRGD, which possesses high affinity for integrin αvβ3 overexpressed in tumor cells and neovasculature. In this multifaceted approach, co-delivery of VEGF siRNA and phenethyl isothiocyanate (PEITC) was employed to target both tumor vascular endothelial cells and tumor cells simultaneously. The co-delivery of VEGF siRNA and PEITC could achieve precise silencing of VEGF, inhibit the accumulation of HIF-1α under hypoxic conditions, and induce apoptosis in tumor cells. In summary, we have successfully developed a nanoparticle delivery platform that utilizes a dual mechanism of action of anti-tumor angiogenesis and pro-tumor apoptosis, which provides a robust and potent strategy for the delivery of anti-cancer therapeutics.
